Effects of esomeprazole magnesium on nonsteroidal anti-inflammatory drug gastropathy

Digestive Diseases and Sciences

Volumn 50, Issue 1, 2005, Pages 86-93

  Koch, Timothy R ^a,d   Petro, Ann ^b   Darrabie, Marcus ^b   Opara, Emmanuel C ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b DUKE UNIVERSITY   (United States)

^c ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Antioxidant; Colon; Esomeprazole; Lipid peroxidation; Mouse; Stomach

Indexed keywords

ANTIOXIDANT; ESOMEPRAZOLE; FREE RADICAL; INDOMETACIN; LIPID PEROXIDE; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM CHLORIDE; OMEPRAZOLE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEATH; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FEEDING; GASTROINTESTINAL TOXICITY; HYPOTHESIS; MELENA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH DISEASE; STOMACH PROTECTION; SURVIVAL; VALIDATION PROCESS; WEIGHT REDUCTION; A J MOUSE; ANIMAL; CHEMICALLY INDUCED DISORDER; LIPID PEROXIDATION; METABOLISM; PATHOPHYSIOLOGY; STOMACH EMPTYING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; GASTRIC EMPTYING; INDOMETHACIN; LIPID PEROXIDATION; MICE; MICE, INBRED A; OMEPRAZOLE; PEROXIDASE; STOMACH DISEASES;

EID: 14544290572     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-1283-z     Document Type: Article

References (48)

1. Koch TR, Yuan L-X, Petro A, Opara EC: Effects of omeprazole and ascorbate on gastric emptying and anti-oxidant levels in a mouse model of glutathione depletion. Dig Dis Sci 47(11):2486-2492, 2002
2. Koch TR, Petro A, Darrabie M, Opara EC: Effect of the H, K-ATPase inhibitor, esomeprazole magnesium, on gut total antioxidant capacity in mice. J Nutr Biochem 15:520-524, 2004
3. Lapenna D, de Gioia S, Ciofani G, et al.: Antioxidant properties of omeprazole. FEBS Lett 382:189-192, 1996
4. Kawamura T, Miyaji C, Toyabe S, et al.: Suppressive effect of antiulcer agents on granulocytes-a role for granulocytes in gastric ulcer formation. Dig Dis Sci 45:1786-1791, 2000
5. Wandall JH: Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut 33:617-621, 1992
6. Suzuki M, Mori M, Miura S, et al.: Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radical Biol Med 21:727-731, 1996
7. Biswas K, Bandyopadhyay U, Chattopadhyay I, et al.: A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 278:10993-11001, 2003
8. Yoshikawa T, Naito Y, Kishi A, et al.: Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 34:732-737, 1993
9. Hassan A, Martin E, Puig-Parellada P: Role of antioxidants in gastric mucosal damage induced by indomethacin in rats. Methods Find Exp Clin Pharmacol 20:849-854, 1998
10. Sener-Muratoglu G, Paskaloglu K, Arbak S, et al.: Protective effect of famotidine, omeprazole, and melatonin against acetylsalicyclic acid-induced gastric damage in rats. Dig Dis Sci 46:318-330, 2001
11. Carlsson E, Larsson H, Mattsson H, Ryberg B, Sundell G: Pharmacology and toxicology of omeprazole with special reference to the effects on the gastric mucosa. Scand J Gastroent 21(Suppl 118):31-38, 1986
12. Pellegrini N, Re R, Yang M, et al.: Screening of dietary carotenoids and carotenoids-rich fruit extracts for antioxidant activities applying 2,2′-azinobis(3-ethylenebenzothiazoline-6-sulfonic acid radical cation decolorization assay. Methods Enzymol 299:379-389, 1998
13. Koch TR, Yuan L-X, Stryker SJ, Ratliff P, Telford GL, Opara EC: Total antioxidant capacity of colon in patients with chronic ulcerative colitis. Dig Dis Sci 45:1814-1819, 2000
14. Abdella N, Al Awadi F, Salman A, et al.: Thiobarbituric acid test as a measure of lipid peroxidation in Arab patients with NIDDM. Diabetes Res 15:173-177, 1990
15. Ballard TC, Farag A, Branum GD, et al.: Effect of L-glutamine supplementation on impaired glucose regulation during intravenous lipid administration. Nutrition 12:349-354, 1996
16. Palmer JM, Koch TR: Altered neuropeptide content and cholinergic enzymatic activity in the inflamed guinea pig jejunum during parasitism. Neuropeptides 18:287-297, 1995
17. Castro GA, Roy SA, Stockstill RD: Trichinella spiralis: Peroxidase activity in isolated cells from the rat intestine. Exp Parasitol 36:307-315, 1974
18. Ruan EA, Rao S, Burdick JS, Stryker SJ, Telford GL, Otterson MF, Opara EC, Koch TR: Glutathione levels in chronic inflammatory disorders of the human colon. Nutr Res 17:463-473, 1997
19. Lang CA, Naryshkin S, Schneider DL, et al.: Low blood glutathione levels in healthy aging adults. J Lab Clin Med 120:720-725, 1992
20. Bicheler V, Cherbut C, Ropert A, et al.: Peptide YY increases gastric emptying in rats. Gastroenterology 114(4):A721, 1998
21. Matsuda M, Aono M, Moriga M, et al.: Centrally administered neuropeptide Y (NPY) inhibits gastric emptying and intestinal transit in the rat. Dig Dis Sci 38:845-850, 1993
22. Galunska B, Marazova K, Tankova T, et al.: Effects of paracetamol and propacetamol on gastric mucosal damage and gastric lipid peroxidation caused by acetylsalicyclic acid (ASA) in rats. Pharmacol Res 46:141-147, 2002
23. Pohle T, Brzozowski T, Becker JC, et al.: Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: Gastroprotection by vitamin C. Aliment Pharmacol Ther 15:677-687, 2001
24. Jaarin K, Gapor MT, Nafeeza MI, et al.: Effect of various doses of palm vitamin E and tocopherol on aspirin-induced gastric lesions in rats. Int J Exp Pathol 83:295-302, 2002
25. Singh P, Bhargava VK, Garg SK: Effect of melatonin and beta-carotene on indomethacin induced gastric mucosal injury. Indian J Physiol Pharmacol 46:229-234, 2002
26. Nafeeza MI, Fauzee AM, Kamsiah J, et al.: Comparative effects of a tocotrienol-rich fraction and tocopherol in aspirin-induced gastric lesions in rats. Asia Pac J Clin Nutr 11:309-313, 2002
27. Sugimoto N, Yoshida N, Yoshikawa T, et al.: Effect of vitamin E on aspirin-induced gastric mucosal injury in rats. Dig Dis Sci 45:599-605, 2000
28. Parmar NS, Tariq M, Ageel AM: Gastric anti-ulcer and cytoprotective effect of selenium in rats. Toxicol Appl Pharmacol 92:122-130, 1988
29. Al-Moutairy AR, Tariq M: Effect of vitamin E and selenium on hypothermie restraint stress and chemically-induced ulcers. Dig Dis Sci 41:1165-1171, 1996
30. Zahavi I, Fisher S, Marcus H, et al.: Oxygen radical scavengers are protective against indomethacin-induced intestinal ulceration in the rat. J Ped Gastroenterol Nutr 21:154-157, 1995
31. Bandyopadhyay B, Bandyopadhyay SK: Protective effect of zinc gluconate on chemically induced gastric ulcer. Indian J Med Res 106:27-32, 1997
32. Herrerias JM, Esteban JM, Caballero-Plasencia AM, et al.: Preventive effect of zaprinast and 3-isobutyl, 1-methylxanthine (phosphodiesterase inhibitors) on gastric injury induced by nonsteroidal anti-inflammatory drugs in rats. Dig Dis Sci 48(5):986-991, 2003
33. Zaror-Behrens G, Greselin E, Madere R, et al.: Vitamin E levels in gastric mucosa and indomethacin-induced gastric lesions in rats. Res Commun Chem Pathol Pharmacol 75:185-192, 1992
34. Stickel F, Meydani M, Wu D, et al.: Effect of vitamin E supplementation on prostaglandin concentrations in aspirin-induced acute gastric injury in aged rats. Am J Clin Nutr 66(5):1218-1223, 1997
35. McAlindon ME, Muller AF, Filipowicz B, et al.: Effect of allopurinol, sulfasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers. Gut 38:518-524, 1996
36. Shea-Donohue T, Steel L, Montcalm-Mazzilli E, et al.: Aspirin-induced changes in gastric function: Role of endogenous prostaglandins and mucosal damage. Gastroenterology 98:284-292, 1990
37. Corak A, Coskun T, Alican I, et al.: The effect of nitric oxide synthase blockade and indomethacin on gastric emptying and gastric contractility. Pharmacology 54:298-304, 1997
38. Kechagias S, Jonsson KA, Norlander B, et al.: Low-dose aspirin decreases blood alcohol concentrations by delaying gastric emptying. Eur J Clin Pharmacol 53:241-246, 1997
39. Rinetti M, Ugolotti G, Calbiani B, et al.: Antiinflammatory drugs and gastric emptying. A comparison between acetylsalicyclic acid and carprofen. Arzneimittelforschung 32:1561-1563, 1982
40. Kulkarni SG, Parikh SS, Shankhpal PD, et al.: Gastric emptying of solids in long-term NSAID users: Correlation with endoscopie findings and Helicobacter pylori status. Am J Gastroenterol 94:382-386, 1999
41. Slomiany BL, Piotrowski J, Slomiany A: Role of endothelin-1 and constitutive nitric oxide synthase in gastric mucosal resistance to indomethacin injury: Effect of antiulcer agents. Scand J Gastroenterol 34:459-464, 1999
42. Chandranath SI, Bastaki SM, Singh J: A comparative study on the activity of lansoprazole, omeprazole, and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat. Clin Exp Pharmacol Physiol 29:173-180, 2002
43. Van den Berg R, Haenen GRMM, Van den Berg H, et al.: Applicability of an improved Trolox equivalent antioxidant capacity measurements of mixtures. Food Chem 66:511-517, 1999
44. Mowat C, Carswell A, Wirz A, et al.: Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology 116:813-822, 1999
45. Martensson J, Jain A, Meister A: Glutathione is required for intestinal function. Proc Natl Acad Sci USA 87:1715-1719, 1990
46. Zhang R, Brennan ML, Shen Z, et al.: Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 277(48):6116-6122, 2002
47. Thomson RD, Lestina LS, Bensen SP, et al.: Lansoprazole-associated microscopic colitis: A case series. Am J Gastroenterol 97:2908-2913, 2002
48. Mukherjee S: Diarrhea associated with lansoprazole. J Gastroenterol Hepatol 18(5):602-603, 2003